Trials / Completed
CompletedNCT04154930
Restylane-L for Correction of Infraorbital Hollows
A Randomized, Evaluator-blinded, Parallel Group, No-treatment Controlled, Multi-center Study to Evaluate the Safety and Effectiveness of Restylane-L® for Correction of Infraorbital Hollows
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 333 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, randomized, evaluator-blinded, no-treatment controlled, parallel group, multi-center US study to evaluate the safety and effectiveness of Restylane-L® for correction of Infraorbital Hollows.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Restylane-L® | Intradermal injection. |
Timeline
- Start date
- 2019-11-11
- Primary completion
- 2021-01-31
- Completion
- 2022-04-06
- First posted
- 2019-11-07
- Last updated
- 2023-04-25
- Results posted
- 2023-04-25
Locations
16 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04154930. Inclusion in this directory is not an endorsement.